About
Eko Health is a medical technology company that reimagines the traditional stethoscope for modern clinical practice. Its suite of digital stethoscopes — including the CORE 500™ and the 3M™ Littmann® CORE Digital Stethoscope — pairs advanced hardware with FDA-cleared AI to help providers detect subtle signs of cardiovascular and pulmonary disease that might otherwise be missed. The platform's AI algorithms are clinically validated to detect heart murmurs, atrial fibrillation (AFib), and low ejection fraction, making providers 2x more likely to identify heart disease compared to standard auscultation. Eko's devices feature digitally enhanced audio with active noise cancellation for clarity in busy clinical environments, real-time waveform visualizations, and integrated 3-lead ECG tracings. Automatic record keeping allows clinicians to store, compare, and share patient exam data over time, supporting longitudinal monitoring and remote second opinions. For health systems, Eko offers the SENSORA® Platform, enabling enterprise-scale deployment with telehealth integrations and life science research capabilities. The solution is HSA/FSA eligible and supports both individual providers and large institutional teams. With 9 FDA clearances and citations in more than 70 peer-reviewed publications, Eko is a clinically rigorous AI health tool for proactive, precise patient care.
Key Features
- FDA-Cleared AI Analysis: Automatically detects heart murmurs, atrial fibrillation (AFib), and low ejection fraction using clinically validated AI algorithms with 9 FDA clearances.
- Enhanced Digital Audio: Active noise cancellation and digital audio amplification deliver crisp, clear heart and lung sounds even in the noisiest clinical environments.
- Real-Time Waveforms & 3-Lead ECG: Visualize heart sounds and ECG tracings during patient exams, combining auditory and visual data for more informed clinical decisions.
- Automatic Record Keeping: Stores patient exam recordings for longitudinal tracking, easy comparison over time, and sharing with colleagues for remote second opinions.
- SENSORA® Platform for Health Systems: Enterprise-scale deployment with telehealth integrations, enabling AI-assisted cardiovascular screening across entire clinical teams and health networks.
Use Cases
- Primary care physicians using AI-assisted auscultation to screen patients for undiagnosed heart murmurs or AFib during routine checkups.
- Cardiologists leveraging real-time ECG tracings and waveform visualizations to make faster, more confident diagnostic decisions.
- Health systems deploying the SENSORA® Platform across clinical teams to standardize cardiovascular screening and reduce missed diagnoses at scale.
- Telehealth providers using Eko-compatible hardware to conduct remote cardiac exams and share recordings with specialists for second opinions.
- Medical researchers and clinical educators using Eko's recorded exam data and published AI models to support cardiovascular studies and training programs.
Pros
- Clinically Validated: Backed by 70+ peer-reviewed publications and 9 FDA clearances, giving clinicians confidence in the accuracy and safety of AI-driven insights.
- Improves Detection Rates: Providers using Eko are 2x more likely to detect heart disease, directly improving patient outcomes through earlier intervention.
- Seamless Telehealth Integration: The SENSORA® Platform integrates with existing health system workflows and telehealth tools, making it scalable from solo practices to large institutions.
- Widely Adopted: With over 700,000 devices sold and thousands of five-star reviews, Eko has a proven track record in real-world clinical settings.
Cons
- Hardware Cost: Requires purchasing dedicated digital stethoscope hardware, which may be a significant upfront investment for some practices or individual providers.
- Subscription Required for Full AI Features: Advanced AI capabilities and record-keeping features are tied to a membership plan, adding ongoing costs beyond the initial device purchase.
- Specialized Use Case: Primarily focused on cardiovascular and pulmonary auscultation, limiting its utility outside of heart and lung assessment workflows.
Frequently Asked Questions
What conditions can Eko AI detect?
Eko's FDA-cleared AI can detect heart murmurs, atrial fibrillation (AFib), and low ejection fraction (a key marker of heart failure) during routine patient exams.
Is Eko Health HSA/FSA eligible?
Yes, Eko devices are HSA/FSA eligible, making them accessible through pre-tax health spending accounts for individual healthcare providers.
How does Eko integrate with telehealth platforms?
The SENSORA® Platform offers telehealth integrations that allow health systems to deploy Eko AI across virtual and in-person care settings, enabling remote auscultation and AI-assisted screening.
Is the AI clinically validated?
Yes. Eko's AI algorithms have been validated in over 70 peer-reviewed clinical publications and have received 9 FDA clearances, ensuring safety and efficacy for clinical use.
Who is Eko Health designed for?
Eko is designed for individual clinicians, cardiologists, primary care providers, and large health systems seeking to improve cardiovascular disease detection during routine examinations.
